Systematic computational strategies for identifying protein targets and lead discovery

被引:1
|
作者
Kataria, Arti [1 ]
Srivastava, Ankit [2 ]
Singh, Desh Deepak [3 ]
Haque, Shafiul [4 ]
Han, Ihn [5 ]
Yadav, Dharmendra Kumar [6 ]
机构
[1] NIAID, Natl Inst Hlth NIH, Lab Bacteriol, NIH, Hamilton, MT 59840 USA
[2] NIAID, Natl Inst Hlth NIH, Lab Neurol Infect & Immun, NIH, Hamilton, MT 59840 USA
[3] Amity Univ Rajasthan, Amity Inst Biotechnol, Jaipur, India
[4] Jazan Univ, Coll Nursing & Hlth Sci, Res & Sci Studies Unit, Jazan 45142, Saudi Arabia
[5] Kwangwoon Univ, Plasma Biosci Res Ctr, Appl Plasma Med Ctr, Dept Elect & Biol Phys, Seoul 01897, South Korea
[6] Gachon Univ, Coll Pharm, Dept Biol, Hambakmoeiro 191, Incheon 21924, South Korea
来源
RSC MEDICINAL CHEMISTRY | 2024年 / 15卷 / 07期
关键词
X-RAY CRYSTALLOGRAPHY; LIGAND-BINDING SITES; DRUG DISCOVERY; MOLECULAR-DYNAMICS; CONNECTIVITY MAP; L-ASPARAGINASE; EXPRESSION SIGNATURES; STRUCTURE PREDICTION; STRUCTURAL BIOLOGY; SCORING FUNCTION;
D O I
10.1039/d4md00223g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Computational algorithms and tools have retrenched the drug discovery and development timeline. The applicability of computational approaches has gained immense relevance owing to the dramatic surge in the structural information of biomacromolecules and their heteromolecular complexes. Computational methods are now extensively used in identifying new protein targets, druggability assessment, pharmacophore mapping, molecular docking, the virtual screening of lead molecules, bioactivity prediction, molecular dynamics of protein-ligand complexes, affinity prediction, and for designing better ligands. Herein, we provide an overview of salient components of recently reported computational drug-discovery workflows that includes algorithms, tools, and databases for protein target identification and optimized ligand selection. Computational algorithms and tools have retrenched the drug discovery and development timeline.
引用
收藏
页码:2254 / 2269
页数:16
相关论文
共 50 条
  • [1] Recent advances in identifying protein targets in drug discovery
    Ha, Jaeyoung
    Park, Hankum
    Park, Jongmin
    Park, Seung Bum
    CELL CHEMICAL BIOLOGY, 2021, 28 (03) : 394 - 423
  • [2] Computational strategies for finding protein targets of flavonoids
    Chen, Hanyong
    Yao, Ke
    Nadas, Janos
    Bode, Ann M.
    Malakhova, Margarita
    Oi, Naomi
    Lubet, Ronald A.
    Dong, Zigang
    CANCER RESEARCH, 2012, 72
  • [3] Early phase drug discovery: Cheminformatics and computational techniques in identifying lead series
    Duffy, Bryan C.
    Zhu, Lei
    Decornez, Helene
    Kitchen, Douglas B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (18) : 5324 - 5342
  • [4] The Computational Methods in Drug Targets Discovery
    Lin, Hao
    CURRENT DRUG TARGETS, 2019, 20 (05) : 479 - 480
  • [5] Computational approaches for identifying potential inhibitors on targeting protein interactions in drug discovery
    Kanakaveti, Vishnupriya
    Shanmugam, Anusuya
    Ramakrishnan, C.
    Anoosha, P.
    Sakthivel, R.
    Rayala, S. K.
    Gromiha, M. Michael
    ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 121, 2020, 121 : 25 - 47
  • [6] Computational Approach to the Discovery of Phytochemical Molecules with Therapeutic Potential Targets to the PKCZ Protein
    Freitas, Poliany G.
    Elias, Thiago C.
    Pinto, Icaro A.
    Costa, Luciano T.
    de Carvalho, Paulo V. S. D.
    Omote, Daniel de Q.
    Camps, Ihosvany
    Ishikawa, Tati
    Arcuri, Helen A.
    Vinga, Susana
    Oliveira, Arlindo L.
    Junior, Walter F. A.
    da Silveira, Nelson J. F.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (05) : 488 - 499
  • [7] Current Strategies in Lead Discovery
    Webb, Maria L.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (07) : 720 - 720
  • [8] Identifying targets for drug discovery using bioinformatics
    Chen, Yi-Ping Phoebe
    Chen, Feng
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (04) : 383 - 389
  • [9] Structure-based lead discovery against protein kinase and phosphatase targets.
    Congreve, MS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U44 - U44
  • [10] Systematic discovery of combinationimmunotherapy targets in vivo
    Cartwright, Adam N.
    Tay, Rong En
    Wucherpfennig, Kai W.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)